Today: 7 February 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

American Airlines stock slips again after Storm Fern chaos — what AAL traders watch next

American Airlines stock slips again after Storm Fern chaos — what AAL traders watch next

American Airlines shares fell 0.9% to $13.43 Wednesday after Winter Storm Fern forced over 9,000 cancellations and is expected to cut first-quarter revenue by up to $200 million. The company maintained its 2026 profit outlook but projected a first-quarter loss of 10 to 50 cents per share. Crews faced long waits and overnight stays in terminals as operations struggled to recover.
28 January 2026
·····
Bank of America stock slips after Fed holds rates: what traders watch next for BAC

Bank of America stock slips after Fed holds rates: what traders watch next for BAC

Bank of America shares fell 1.2% to $51.52 after the Federal Reserve left interest rates unchanged and gave little guidance on future cuts. The bank told staff it will match the U.S. government’s $1,000 “Trump Account” contribution for eligible employees’ children. Vito Lo Piccolo was named country executive for Italy, replacing Nino Mattarella. The S&P 500 briefly touched 7,000 before retreating as markets awaited Fed Chair Powell’s remarks.
28 January 2026
····
P&G stock drops nearly 1% as TD Cowen downgrades; investors weigh tariffs and a new Wonderbelly buy

P&G stock drops nearly 1% as TD Cowen downgrades; investors weigh tariffs and a new Wonderbelly buy

Procter & Gamble shares fell 1% to $146.89 Wednesday after TD Cowen downgraded the stock, citing weak pricing power and increased promotions. The company announced a Wonderbelly acquisition and a new Crest toothpaste launch. Chief Brand Officer Marc Pritchard sold nearly 96,000 shares at an average of $151.15. P&G raised U.S. prices by up to 2.5% to offset tariffs.
28 January 2026
····
Gilead stock dips as Medicare targets Biktarvy for 2028 price talks — and Trodelvy gets a guideline lift

Gilead stock dips as Medicare targets Biktarvy for 2028 price talks — and Trodelvy gets a guideline lift

Gilead Sciences shares fell 1.3% to $139.19 Wednesday afternoon after Medicare named its HIV drug Biktarvy for 2026 price negotiations, with caps set to start in 2028. The company also reported its cancer drug Trodelvy was upgraded to “category 1” in new NCCN breast cancer guidelines. Investors await Gilead’s earnings on Feb. 10.
28 January 2026
··
Rocket Lab stock rises again as RKLB traders focus on Neutron “Hungry Hippo” milestone, Feb. 26 earnings

Rocket Lab stock rises again as RKLB traders focus on Neutron “Hungry Hippo” milestone, Feb. 26 earnings

Rocket Lab shares rose 2.7% to $89.32 in Wednesday afternoon trading, extending gains after a recent drop. Investors are watching for updates on the Neutron rocket program after a test tank ruptured last week. The company will report earnings on Feb. 26, with no guidance yet on Neutron’s timeline. Volatility remains high as traders react to development news.
28 January 2026
·····
UPS stock price drops 3% as Amazon pullback and 30,000-job cut plan sink in

UPS stock price drops 3% as Amazon pullback and 30,000-job cut plan sink in

UPS shares fell 3.2% to $103.82 Wednesday after the company said it will cut up to 30,000 jobs and close 24 facilities in 2026, reducing Amazon deliveries. UPS warned revenue will dip in early 2026 before recovering, and forecast full-year revenue of $89.7 billion. The board approved a $1.64 quarterly dividend. Teamsters said members are likely to reject the company’s buyout offer.
28 January 2026
···
ServiceNow stock slips before earnings as Fed holds rates — what to watch in NOW shares

ServiceNow stock slips before earnings as Fed holds rates — what to watch in NOW shares

ServiceNow shares fell 1.2% to $130.24 Wednesday afternoon as investors awaited quarterly earnings due after the bell. Wall Street focused on subscription growth and backlog, with analysts expecting revenue of $3.53 billion, up 19% year-over-year. The Fed held rates steady, pressuring tech stocks. ServiceNow recently expanded its AI partnership with OpenAI.
28 January 2026
·····
HCA Healthcare stock slides as traders digest $10B buyback, 2026 outlook and ACA headwinds

HCA Healthcare stock slides as traders digest $10B buyback, 2026 outlook and ACA headwinds

HCA Healthcare shares fell 2.8% to $491.72 Wednesday, erasing some of Tuesday’s 11% rally after earnings. The company set 2026 EPS guidance at $29.10–$31.50 and announced a $10 billion share buyback. Investors weighed cost cuts against risks from changes in ACA coverage and payer mix. Fourth-quarter revenue rose 6.7% to $19.51 billion, with net income up 30.6% to $1.88 billion.
28 January 2026
·····
Coinbase stock edges up as UK bans ‘Everything is Fine’ ads and prediction markets draw heat

Coinbase stock edges up as UK bans ‘Everything is Fine’ ads and prediction markets draw heat

Coinbase shares rose 0.2% to $211.24 Wednesday after UK regulators banned a Coinbase ad campaign over crypto risk messaging tied to cost-of-living concerns. The company is expanding into stock trading and event contracts as regulatory scrutiny intensifies. Coinbase’s next earnings report is due Feb. 12. Bitcoin climbed 1.3% to about $89,294.
28 January 2026
···
1 … 144 145 146 147 148 … 1,008

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
Go toTop